Daily Mail: An implantable miniature telescope has received FDA approval for use in the US.
The device was developed by VisionCare to treat end-stage age-related macular degenerationâmdash;when a blind spot develops in the central vision of the eye.Implanted in the cornea, the device expands an incoming image onto the peripheral parts of the retina that are undamaged from AMD, thereby reducing the blind spot’s effect. So far, the device is slated for use in people over the age of 75 and doesn’t treat AMD directly; it can only be implanted in one eye, and the patient has to learn how to merge the two images rendered in order to see.
